✦ LIBER ✦

Glycemic control and cardiovascular disease in Type 2 diabetes: a review

✍ Scribed by Sarah H. Wild; Christopher J. Dunn; Paul M. McKeigue; Sylvie Comte

Publisher: John Wiley and Sons
Year: 1999
Tongue: English
Weight: 106 KB
Volume: 15
Category: Article
ISSN: 1520-7552
DOI: 10.1002/(sici)1520-7560(199905/06)15:3<197::aid-dmrr28>3.0.co;2-f

No coin nor oath required. For personal study only.

✦ Synopsis

Cardiovascular disease is the major cause of morbidity and mortality in people with Type 2 diabetes, and risk of atherosclerotic disease is markedly increased in people with diabetes compared to people with normal glucose tolerance. The excess risk can not be completely explained by increased prevalence of other cardiovascular disease risk factors such as hypertension and hyperlipidaemia in people with diabetes. This review examines the role of hyperglycemia and glycemic control in cardiovascular disease in people with Type 2 diabetes. The results of prospective observational studies and randomized controlled trials are summarized. We conclude that control of hypertension and hyperlipidemia are important to reduce risk of cardiovascular disease in people with diabetes and may be more easily achieved than tight glycemic control.

📜 SIMILAR VOLUMES

Glycaemic control and cardiovascular ris

Glycaemic control and cardiovascular risk factors in Type 2 diabetes: a population-based study

✍ Bruno, G.; Cavallo-Perin, P.; Bargero, G.; Borra, M.; D’Errico, N.; Pagano, G. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB 👁 2 views

The objective of this study was to estimate the prevalence of poor glycaemic control and cardiovascular risk factors in an Italian population-based cohort of subjects with Type 2 diabetes mellitus (DM). Out of a cohort of 1967 subjects (estimated completeness of ascertainment 80 %), 1574 (80 %) were

Hormone replacement therapy in Type 2 di

Hormone replacement therapy in Type 2 diabetes mellitus: a cardiovascular perspective

✍ Sattar, N.; McKenzie, J.; MacCuish, A.C.; Jaap, A.J. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

Until recently, a diagnosis of diabetes was considered a relative contraindication for hormone replacement therapy (HRT) in post-menopausal women. This is reflected by an uptake of HRT of only around 10 % (approximately half that in the non-diabetic population). 1,2 However, a recent series of revie

Insulin resistance, cardiovascular risk

Insulin resistance, cardiovascular risk factors and ultrasonically measured early arterial disease in normotensive Type 2 diabetic subjects

✍ C. Kong; T. Elatrozy; V. Anyaoku; S. Robinson; W. Richmond; R. S. Elkeles 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

Coronary disease, dyslipidaemia and clin

Coronary disease, dyslipidaemia and clinical trials in type 2 diabetes mellitus

✍ Watts, Gerald F. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 1 views

Type 2 diabetes, cardiovascular disease,

Type 2 diabetes, cardiovascular disease, and the evolutionary paradox of the polycystic ovary syndrome: A fertility first hypothesis

✍ Stephen J. Corbett; Anthony J. McMichael; Andrew M. Prentice 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 364 KB

Glycaemic control and development of ret

Glycaemic control and development of retinopathy in Type 2 diabetes mellitus: a longitudinal study

✍ P.-J. Guillausseau; P. Massin; M.-A. Charles; H. Allaguy; Z. Güvenli; M. Virally 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB 👁 1 views

Relationships between glycaemic control, hypertension, and development of microangiopathy have been well documented in Type 1 (insulin-dependent) but not in Type 2 (noninsulin-dependent) diabetes mellitus. Therefore, we have investigated these relationships in a cohort of 64 Type 2 patients free of